(NASDAQ: NTRA) Natera's forecast annual revenue growth rate of 16.8% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.95%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.34%.
Natera's revenue in 2026 is $2,500,925,000.On average, 22 Wall Street analysts forecast NTRA's revenue for 2026 to be $404,153,808,004, with the lowest NTRA revenue forecast at $370,068,547,088, and the highest NTRA revenue forecast at $423,201,453,810. On average, 22 Wall Street analysts forecast NTRA's revenue for 2027 to be $478,482,591,262, with the lowest NTRA revenue forecast at $437,666,207,392, and the highest NTRA revenue forecast at $518,296,467,458.
In 2028, NTRA is forecast to generate $575,296,189,494 in revenue, with the lowest revenue forecast at $508,844,252,246 and the highest revenue forecast at $658,790,757,200.